IQVIA Holdings Inc.

IQVNYSE • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
279.36 USD
↗ 1.04 (0.37%)AT CLOSE (03:59 PM EDT)
274.81
↘ 4.55 (1.63%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
274.81
↘ 4.55 (1.63%)
🔴Market: CLOSED

IQVIA Holdings Inc. (IQV) trades at $279.36 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, exceptional Return on Equity (22.3%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place IQV at a fair price relative to peers.

Technical & fundamental data as of Oct 23, 2026.

Open?$276.56
High?$279.58
Low?$274.67
Prev. Close?$278.32
Volume?981.2K
Avg. Volume?1.5M
VWAP?$279.39
Rel. Volume?0.65x
Bid / Ask
Bid?$277.00 × 100
Ask?$285.00 × 100
Spread?$8.00
Midpoint?$281.00
Valuation & Ratios
Market Cap?46.0B
Shares Out?164.6M
Float?149.6M
Float %?90.9%
P/E Ratio?33.44
P/B Ratio?7.45
EPS?$8.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Themes
Biotech - Drug Development›Clinical-Stage PlatformsDigital Health & Telemedicine›Health IT & Data Infrastructure
Employees
94.0K
Market Cap
45.8B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Website
www.iqvia.com
Listed
2013-05-09
Address
2400 ELLIS ROAD
DURHAM, NC 27703
Phone: 919-998-2000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
66
Momentum?
62
Short Sent.?
94
Piotroski F-Score?4/9Mixed
Altman Z-Score?2.84Safe
Confidence?68%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.15%Low
Short Interest?3.2M
Days to Cover?1.7
Free Float149.6M
Avg Daily Volume1.8M
Settlement Date2026-09-30
Financial Health
Current Ratio?0.71Weak
Quick Ratio?0.71Weak
Cash Ratio?0.22Low
Debt/Equity?2.59High
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
67/100
P/E?
Peers
100
S&P
26
33.4PRICEY▾
P/B?
Peers
27
S&P
25
7.45FAIR▾
P/S?
Peers
100
S&P
54
2.71CHEAP▾
P/FCF?
Peers
100
S&P
52
21.1FAIR▾
EV/EBITDA?
Peers
100
S&P
38
17.0FAIR▾
EV/Sales?
Peers
100
S&P
53
3.54FAIR▾
Returns & Efficiency
ROE?
Peers
80
S&P
70
22.3%STRONG▾
ROA?
Peers
30
S&P
42
4.6%FAIR▾
Cash Flow & Enterprise
FCF?$2.2B
Enterprise Value?$60.1B
Fundamentals ratios updated end of day
MarketsMoversWatchlist